Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

After almost 50 years at Oxford, Professor Dame Kay Davies is soon to retire – well…. mostly… Kay talks to Sarah Whitebloom about her early years at Somerville fresh out of state school, how she balanced motherhood with the demands of her burgeoning career, and her long held passion to find a cure for Duchenne muscular dystrophy. Thank you Kay for your long years of service and dedication. You are truly an inspiration to many!

Professor Dame Kay Davies

In spite of everything, many people still underestimate women, in general, and older women, in particular. They have clearly never encountered Kay Davies, the dynamic 70-year-old Oxford geneticist, who is ‘retiring’ after a lifetime’s research (but not really).  Just a few minutes immersed in the company of the self-effacing-but-determined Professor Dame, is enough to make anyone exhausted and put paid to stereotypes about women.

Forget about older women being invisible, you could not miss Professor Davies, who arrives promptly for her interview, lovely in a hallmark brightly coloured jacket (more of which later).

But the professor’s story is even more arresting than her striking appearance. Having arrived in Oxford more than 50 years’ ago, Professor Davies has worked with some of the leading medical scientists of the last half century.

She has been tirelessly at the cutting-edge of genetic science; is close to a cure for a devastating genetic condition – and has found time to be a member of the Council of the Medical Research Council, Deputy Chair of the Wellcome Trust and hold a variety of other posts. Professor Davies has been honoured in the UK (a CBE, followed by a DBE in 2008) and in the US (by the American Society of Human Genetics) – oh...and she has a family.

Read the full interview with Professor Dame Kay Davies

Similar stories

Drug could help diabetic hearts recover after heart attack - Oxford research

Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.

Largest ever global study of tuberculosis identifies genetic causes of drug resistance

Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.

Anti-cancer drug derived from fungus shows promise in clinical trials

A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.